Transthoracic echocardiography is often used to screen patients prior to non-cardiac surgery to detect conditions associated with perioperative haemodynamic compromise and to stratify risk. However, anaesthetists' use of echocardiography is quite variable. A consortium led by the American College of Cardiology Foundation has developed appropriate use criteria for echocardiography. At Joondalup Hospital in Western Australia, we have used these criteria to order echocardiographic studies in patients attending our anaesthetic preadmission clinic. We undertook this audit to determine the incidence of significant echocardiographic findings using this approach. In a 22-month period, 606 transthoracic echocardiographic studies were performed. This represented 8.7% of clinic attendees and 1.7% of all surgical patients. In about two-thirds of the patients, the indication for echocardiography was identified on the basis of a telephone screening questionnaire. The most common indications were poor exercise tolerance (27.4%), ischaemic heart disease (20.9%) and cardiac murmurs (16.3%). Over 26% of patients studied had significant cardiac pathology (i.e. moderate or severe echocardiographic findings), most importantly moderate or severe aortic stenosis (8.6%), poor left ventricular function (7.1%), a regional wall motion abnormality (4.3%) or moderate or severe mitral regurgitation (4.1%). Using appropriate use criteria to guide ordering transthoracic echocardiography studies led to a high detection rate of clinically important cardiac pathology in our perioperative service.
As anaesthetic and surgical morbidity and mortality have reduced over the past 10 to 20 years, increasing numbers of patients with significant cardiac pathology present for elective or semielective surgery. In our experience, patients with seemingly similar symptomatology vary from having an essentially normal heart to having severe cardiac pathology when studied using echocardiography.
There are significant variations in anaesthetic practice with regard to the use of preoperative transthoracic echocardiography (TTE) with few guidelines. For example, some anaesthetists request a TTE for any undiagnosed systolic murmur. However, despite the known error rate with clinical assessment alone, even by cardiologists 1 , others will be selective on the basis of history and clinical examination findings. Many will order a TTE if there is exercise-induced shortness of breath of unknown cause, but few will do so when exercise intolerance is indeterminate (e.g. because exercise is limited primarily by an orthopaedic or other disability).
A consortium led by the American College of Cardiology Foundation (ACCF), including the American Society of Echocardiography (ASE) and the American Heart Association (AHA), has developed and published the appropriate use criteria for echocardiography (ACCF AUC) 2 . We considered the possibility that using these criteria for obtaining preoperative TTE may improve the detection of clinically important cardiac pathology and thereby improve risk assessment and perioperative planning.
A small number of reviews [3] [4] [5] and case series [6] [7] [8] have been published showing the benefits of perioperative TTE in terms of changes in surgical and anaesthetic management. These TTE studies have been performed largely on an ad hoc basis and mostly on the day of surgery.
Because of time or other constraints, it may be difficult to obtain a TTE in a timely fashion from cardiology services. Furthermore, anaesthetist involvement in the performance of preoperative TTE studies is a rapidly developing field. At Joondalup Hospital in Perth, Western Australia, we have established a preoperative TTE service as a supplement to our anaesthetic pre-admission clinic. We employ an experienced cardiac sonographer to perform the scans and have two anaesthetists who are fully credentialled in TTE to report the studies. The service is funded by Medicare Australia rebates. We have standardised our threshold for ordering preoperative TTE studies, ordering a study whenever a patient meets an appropriate indication in the ACCF AUC. Studies are ordered either as a result of a telephone questionnaire prior to attendance at the clinic or by the anaesthetist at any clinic visit.
There have been no reports to date on the incidence of significant echocardiographic findings in a pre-anaesthetic clinic using fixed indications such as the ACCF AUC. The aim of this audit was to determine the incidence and nature of clinically important cardiac pathology in patients presenting to an anaesthetic pre-admission clinic in a general (non-cardiac) hospital setting, using TTE directed by the ACCF AUC.
METHODS
Joondalup Hospital is a 410-bed general hospital in Perth, Western Australia. It offers most types of surgery, excluding cardiothoracic surgery, neurosurgery, transplant surgery, tertiary level obstetrics and neonatal surgery. A subset of patients have their assessment in our anaesthetic pre-admission clinic depending on their procedure, anticipated length of stay and the findings of a screening questionnaire. Since May 2009, the clinic has included a TTE service with an accredited cardiac sonographer, using either a Vivid 7 (GE Healthcare, Milwaukee, WI) or less commonly a Sonosite M-Turbo (SonoSite, Inc., Bothell, WA). Studies are reported by one of two consultant anaesthetists both of whom have passed the ASCExAM (US National Board of Echocardiography) and who exceed the Level II training and continuing competence requirements for cardiologists specialising in adult echocardiography 9 as defined by the American College of Cardiology (ACC) and the AHA. Both are fully credentialled in diagnostic echocardiography by the hospital. Images are reported and archived using Prosolv (Fujifilm Software, Indianapolis, IN). Studies are reviewed independently as a part of the normal quality control processes established in the clinic.
The ASE recommendations for perioperative echocardiography 10 assume that images will be both acquired and reported by appropriately trained physicians and do not envisage image acquisition by a trained sonographer. With this exception, the service in our clinic meets the requirements of this document.
Appropriateness for TTE is determined using the ACCF AUC. These guidelines give an appropriateness score on a scale of 1 to 9, where 1 is highly inappropriate and 9 is most appropriate, for a large number of possible indications for echocardiography. Scores 7 to 9 are rated ' A' or appropriate, scores of 4 to 6 indicate 'U' or uncertain, while those with a score of 1 to 3 are rated 'I' or inappropriate.
Patients are selected to attend the pre-admission clinic if it is anticipated that they will require an overnight stay in hospital postoperatively (other than for social reasons) or if the nurses identify comorbid disease on the screening questionnaire. Patients are not required to attend the clinic before minor procedures (such as an endoscopy) or procedures using local anaesthetic (with or without sedation). Every patient selected to attend the clinic is also reviewed to determine if they have an appropriate indication for a TTE study with a score of 7 to 9 in the ACCF AUC. If a patient has an appropriate indication, the patient will be asked if they have had a TTE within the last year. If they have had one, an attempt is made to get the results. If the patient has not had a TTE in the last year or the results of a recent TTE cannot be obtained, they are referred for a new study. For the initial five months of the TTE service anaesthetists took the responsibility for ordering studies at the time they saw patients in the clinic.
Selection of patients to attend the clinic includes the results of a nurse-administered telephone questionnaire. From the end of October 2009, this questionnaire has also been used to determine, where possible, if a patient has an appropriate indication for a TTE study, usually allowing for the results of any study to be available when the patient is first seen by an anaesthetist at the clinic. Where possible, the TTE and anaesthetist consultation are organised for the same day. The anaesthetist seeing the patient is still able to order a TTE if an appropriate indication is identified which may not detected in the telephone screening. The process is shown in Figure 1 .
TTE studies are reported in accordance with standard guidelines and using grading criteria published by the ASE [11] [12] [13] [14] [15] [16] . For the purposes of this audit, echocardiographic findings of moderate or severe cardiac pathology, using the ASE grading criteria, were classified as significant.
With institutional ethical approval (approval number 1201), we prospectively audited data from the pre-admission clinic and the TTE service.
RESULTS
This audit covered the 22 months from May 2009 to February 2011. During this time there were 31,296 operations at the hospital. Of these, 6609 (21.2%) patients were seen in the anaesthetic pre-admission clinic. A total of 572 patients (8.7% of those attending the clinic and 1.8% of all patients) had a TTE study. There were an additional 34 patients, mainly with undiagnosed murmurs, referred from the antenatal clinic. All these obstetric patients also had an appropriate indication for echocardiography. As a result there were a total of 606 TTE studies during the audit period.
From Of the 283 patients identified by the screening questionnaire, 45 (21.1% of 283) had their TTE study on a day before seeing the anaesthetist and 168 (78.9%) had both their TTE study and preadmission clinic visit on the same day. Despite being identified as having an indication for TTE through the screening questionnaire, there were 70 patients (24.7%) for whom the study could not be performed on or before the day they saw the anaesthetist.
The breakdown of the sources of study referrals are summarised in Figure 2 .
The types of surgery are shown in Table 1 . The indications for the TTE studies are shown in Table 2 . Cardiac investigations refers to studies ordered by an anaesthetist for indications such as assess LV function or transient ischaemic attackpossible embolic source; none of the patients in this category had a TTE study as a result of the screening questionnaire.
Overall, 101 (16.7% of 606) patients had normal studies and 338 (55.8%) had at least one finding of cardiac pathology graded mild. A total of 167 (27.6%) had significant abnormal findings, 127 (21.0%) at least one finding graded moderate and 40 (6.6%) at least one finding graded severe. A selection of pathologies demonstrated is shown in Table 3 . Some patients are represented more than once in this table.
There were 99 patients referred for investigation of a cardiac murmur. Ninety-two of these patients had a systolic murmur and the findings for these patients are summarised in Table 4 . Of the other seven patients where the nature of the murmur was not specified, four had no obvious cause found, one had mild aortic stenosis and two had aortic regurgitation (one mild and the other of moderate severity).
The 165 patients with poor exercise tolerance had no significant findings in 135 cases (81.8%), cardiac 
DISCUSSION
This audit reports on the use of TTE in an anaesthetic pre-admission clinic where we undertook studies on any patient with an appropriate indication in accordance with the ACCF appropriate use criteria. This use of TTE is more extensive than has been traditional in Australia. Despite this lower than traditional threshold for the use of preoperative TTE, 27.6% of patients had at least one moderate or severe echocardiographic abnormality. In addition, there were 75 patients (12.4%) with a heart murmur in whom moderate or severe valvular heart disease was able to be excluded. We consider this a high proportion of patients with clinically useful TTE results.
An appropriate preoperative assessment is the foundation on which safe perioperative management decisions can be made. A significant part of any assessment is to identify patients at risk of perioperative complications 17 . The use of a pre-admission screening questionnaire is a tool designed to maximise efficiency so that the relevant echocardiographic information is available to the anaesthetists when they assess the patient and also to reduce the number of potentially inappropriate TTE studies performed.
Previous perioperative series from Australia using focussed or limited TTE have been reported by Canty 4 and Cowie 5 . When studies were preoperative, they were largely conducted on the day of surgery, typically in the preoperative waiting area or anaesthetic room. Table 5 shows the indications for studies in our audit compared to these other audits (Canty, breakdown of indications, personal communication). The proportion of studies performed for murmurs were higher in these series. As the two earlier series were perioperative and not just preoperative, they also reported a higher number of studies performed for investigation of haemodynamic instability, an unlikely indication in a pre-admission clinic setting. A minority of their indications was for poor exercise tolerance or a non-specific history of ischaemic heart disease, whereas these indications were the majority in our audit. Similarly, the incidence of normal studies was higher in our audit, consistent with the less acute clinical setting.
More recently, Canty has reported on the impact of 100 focussed TTEs conducted in a pre-anaesthetic clinic 8 . Using largely the same definitions as we have used, he reports an overall 31% of patients with significant TTE findings. This proportion of abnormalities and the range of pathologies is similar to ours. Including both enhancements in anaesthetic and surgical management as a result of significant pathology and downgrades in management when clinical concerns could be allayed, Canty 8 showed that together, 54% of patients had some change in plan, albeit some in a relatively minor way.
The AHA and ACC have published guidelines on the assessment of perioperative cardiovascular risk, last updated in 2007 18 . However, these recommendations are heavily weighted towards the work by cardiologists in the prevention of the complications of ischaemic heart disease in major surgery. They have less concern for other cardiac pathology and the impact on perioperative haemodynamic stability. Wijeysundera et al 19 reported on preoperative TTE in the context of cardiological intervention. They raised the possibility of a negative impact of preoperative TTE screening if it permitted excessive β blockade in low-risk patients. We do not consider this study relevant to our situation.
Rohde et al 20 reported on 570 of 4325 patients who had TTE prior to major non-cardiac surgery. In univariate analyses, major cardiac complications were associated with any degree of preoperative systolic dysfunction (odds ratio [OR] 2.8, 95% confidence interval [CI] 1.1 to 7.0), moderate to severe left ventricular hypertrophy (OR 2.2, 95 % CI 1.1 to 4.3), moderate to severe mitral regurgitation (OR 2.3, 95% CI 1.2 to 4.6) and increased aortic valve gradients (OR 6.3, 95% CI 1.5 to 26) and concluded that TTE could be useful in any preoperative assessment. Halm 21 showed that patients with a left ventricular ejection fraction of less than 40% have a threefold increased mortality over those with a normal or near normal ejection fraction. Although a normal resting ejection fraction does not exclude the potential for perioperative cardiovascular complications, the added knowledge of low ejection fraction will influence the perioperative management of patients and their disposition to high dependency care after surgery. Although we conducted a prospective audit, our data is an audit of a clinical service and is not the result of a prospective randomised trial. It had been our intention, whenever possible, to screen patients before they attended the clinic so that the anaesthetists at the clinic had the fullest clinical information available at the first visit. It would not have been appropriate to blind the anaesthetist to the TTE result before they saw the patient. Therefore, we cannot determine whether the attending anaesthetist would have diagnosed the cardiovascular disorder on clinical grounds alone.
All TTEs performed were complete studies, with scans performed by an experienced cardiac sonographer, formally reported by one of two fully credentialled anaesthetists and in a setting where it was also possible to charge Medicare Australia for the studies to approximately cover our costs. In most hospitals in Australia, anaesthetist-led preoperative TTE studies are more likely to be limited goaldirected scans. We are unable to determine if the same information could have been obtained by using the same patient selection criteria but performing limited or goal-focussed studies. However, work by Rugulotto 22 and others suggest limited studies have a lower pickup rate than comprehensive studies.
Until we established our service and gathered data on the incidence of findings, we only had anecdotal evidence that the incidence of abnormal echocardiographic in preoperative patients meeting the ACCF AUC would be high. Now that we know the incidence using the ACCF AUC and comprehensive formal echocardiography, it is possible to consider alternative models, to study the incidence of findings using goal directed studies, to study the relative costs between models and to power these future studies.
The reading anaesthetist simultaneously collected data for both clinical purposes and the audit. This was not an audit of the ability of the consultant anaesthetists (both of whom meet ACC and AHA training and competency standards for independent practice in adult echocardiography) to report TTE studies. The reporting anaesthetists did have the benefit of an initial report from the cardiac sonographer. A proportion of the studies were subject to our usual quality control procedures or were reviewed as a part of ongoing training in echocardiography in the hospital. While no attempt was made to re-read all the studies purely for the purposes of this audit, we are confident the echocardiographic data as reported are reliable.
There is a limitation in our use of ASE gradings for our echocardiographic findings. These gradings were not developed for, and so may not correlate with perioperative significance. For example, we consider moderate or severe left atrial enlargement in isolation of lesser significance than any moderate or severe left ventricular diastolic function or moderate or severe mitral valve disease that might be causing such atrial enlargement. On the other hand, some would argue that even mild right ventricular systolic failure is significant. In his pre-admission clinic series, Canty 6 did not report any patients with significant atrial enlargement or significant aortic root dilatation. If we remove patients with only a significant left atrial enlargement or significant aortic root dilatation from our significant findings, there were still 140 (23.1%) with at least one significant finding.
However, there are no accepted equivalent published perioperative gradings for echocardiographic findings against which to analyse our data. Therefore, our primary report is that of the proportion of patients with any significant (moderate or severe) echocardiographic abnormalities using the existing well-established ASE gradings. Anaesthetists are already familiar with these gradings and can interpret our findings accordingly.
Only resting and not stress echocardiography is employed in our clinic. As occurs with resting rather than stress electrocardiography, resting only echocardiography may underestimate the severity of ischaemic heart disease. A heart with a normal ejection fraction and no wall motion abnormalities can become severely impaired under the stress of anaesthesia and surgery. Anaesthetists in the clinic could order a stress test if they considered that an inducible worsening of ischaemic heart disease was likely on clinical grounds. Such considerations were beyond the scope of our study.
We used the ACCF AUC published in 2007. An update of these guidelines was provided in 2011 23 . The 2011 guidelines have a new indication, "13 Routine perioperative evaluation of ventricular function with no symptoms or signs of cardiovascular disease I (2) ." In other words, the taskforce, using evidencebased medicine, and practice experience scored this indication as inappropriate (i.e. TTE isn't generally acceptable) nor a reasonable approach for this indication. However, in the preamble there is the comment: "The indications for the perioperative evaluation for noncardiac surgery were modelled after the ACCF/AHA guidelines on perioperative cardiovascular evaluation and care for non-cardiac surgery. If a patient has signs/symptoms of suspected cardiac aetiology, the clinical scenario should be considered in the symptomatic category (e.g. Indication 1) and not in the perioperative section."
We believe that our screening, although based on the 2007 AUC, remains consistent with the 2011 AUC.
We recognise that the ACCF AUC was designed first and foremost by cardiologists for cardiologists. However, these guidelines are advice from cardiologists on the circumstances in which echocardiography is important to supplement clinical examination. There is no suggestion in the document that this advice is limited only to cardiology. The quote from the 2011 ACCF AUC (on the previous page) implies the ACCF considered these AUC as appropriate for perioperative medicine. On the other hand, there are no other published AUC that have been developed purely for the perioperative setting and which we might have used instead. However, having used the ACCF AUC, we believe the incidence of significant findings suggests they are appropriate for the preoperative use to which we have put them.
Although not the primary aim of this audit, we consider our use of a questionnaire to identify patients meeting the AUC was both practical and justified. We were able to identify 66% of patients with an appropriate indication for echocardiography using our telephone screening questionnaire and were thus able to have the results of any study available at the first clinic visit in the majority of cases.
In summary, we have undertaken TTE studies in a preoperative anaesthetic clinic using a telephone questionnaire method and the clinical consultation with the anaesthetist to identify those patients meeting the ACCF AUC. Using these criteria for ordering studies, we found 27.6% of patients had at least one moderate or severe abnormal echocardiographic finding.
